$LYNX Solexa, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Solexa, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Solexa, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Solexa, Inc. for free.
IRS Number: 943161073
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Trading Symbol: LYNX
Company Address: 25861 INDUSTRIAL BLVD HAYWARD 94545
Former name: LYNX THERAPEUTICS INC, date of change: 1993-10-08
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
Solexa, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 02 2007 | LYNX | Solexa, Inc. | ILLUMINA INC | 10% Owner | Buy | J | 0.00 | 38,122,885 | 0 | 43,277,524 | 5.2 M to 43.3 M (+739.58 %) |
| Jan 30 2007 | LYNX | Solexa, Inc. | Rubinstein Linda M | VP and CFO | Option Exercise | D | 8.60 | 75,000 | 645,000 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Rubinstein Linda M | VP and CFO | Option Exercise | D | 5.97 | 25,000 | 149,250 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Rubinstein Linda M | VP and CFO | Option Exercise | D | 6.11 | 141,000 | 861,510 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | SIEGEL BROCK M | COO | Sell | D | 0.00 | 156,000 | 0 | 0 | 156 K to 0 (-100.00 %) |
| Jan 30 2007 | LYNX | Solexa, Inc. | Omead Ostadan | VP Marketing | Option Exercise | D | 8.60 | 75,000 | 645,000 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Omead Ostadan | VP Marketing | Option Exercise | D | 6.11 | 50,000 | 305,500 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Lussier Richard H | VP Sales and Field ... | Option Exercise | D | 8.30 | 75,000 | 622,500 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Lundberg Peter | VP and Chief Techni ... | Option Exercise | D | 8.60 | 30,000 | 258,000 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Lundberg Peter | VP and Chief Techni ... | Option Exercise | D | 5.97 | 40,000 | 238,800 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Lundberg Peter | VP and Chief Techni ... | Option Exercise | D | 6.11 | 50,000 | 305,500 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Smith Tony | VP & Chief Scientif ... | Option Exercise | D | 8.60 | 75,000 | 645,000 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Smith Tony | VP & Chief Scientif ... | Option Exercise | D | 5.97 | 88,000 | 525,360 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Smith Tony | VP & Chief Scientif ... | Option Exercise | D | 1.28 | 4,088 | 5,233 | 0 | |
| Jan 30 2007 | LYNX | Solexa, Inc. | Smith Tony | VP & Chief Scientif ... | Option Exercise | D | 1.28 | 4,088 | 5,233 | 0 |